Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.

Penack O, Henke E, Suh D, King CG, Smith OM, Na IK, Holland AM, Ghosh A, Lu SX, Jenq RR, Liu C, Murphy GF, Lu TT, May C, Scheinberg DA, Gao DC, Mittal V, Heller G, Benezra R, van den Brink MR.

J Natl Cancer Inst. 2010 Jun 16;102(12):894-908. doi: 10.1093/jnci/djq172. Epub 2010 May 12.

2.

[Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].

Wang SH, Li DP, Zhang YJ, Zhang P, Zeng LY, Pan XY, Xu KL, Huang YH.

Zhonghua Xue Ye Xue Za Zhi. 2012 Feb;33(2):88-93. Chinese.

PMID:
22730654
3.

Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.

Liao F, Doody JF, Overholser J, Finnerty B, Bassi R, Wu Y, Dejana E, Kussie P, Bohlen P, Hicklin DJ.

Cancer Res. 2002 May 1;62(9):2567-75.

4.

[Influence of donor T(reg) cells on GVHD and hematopoietic reconstitution after allogeneic bone marrow transplantation in mice].

Yang K, Liu QF, Fan ZP, Zhang Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Jun;15(3):547-52. Chinese.

PMID:
17605863
5.

Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma.

Sun XT, Yuan XW, Zhu HT, Deng ZM, Yu DC, Zhou X, Ding YT.

World J Gastroenterol. 2012 Sep 21;18(35):4925-33.

6.
8.

[Prophylaxis of graft-versus-host disease in mice by chemical modification of graft and OX40-OX40L costimulatory pathway.].

Huang YH, Feng SR, DU B, Xu KL, Pan XY.

Zhonghua Xue Ye Xue Za Zhi. 2009 Nov;30(11):735-40. Chinese.

PMID:
20137307
9.

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.

Lu SX, Kappel LW, Charbonneau-Allard AM, Atallah R, Holland AM, Turbide C, Hubbard VM, Rotolo JA, Smith M, Suh D, King C, Rao UK, Yim N, Bautista JL, Jenq RR, Penack O, Na IK, Liu C, Murphy G, Alpdogan O, Blumberg RS, Macian F, Holmes KV, Beauchemin N, van den Brink MR.

PLoS One. 2011;6(7):e21611. doi: 10.1371/journal.pone.0021611. Epub 2011 Jul 6.

10.

Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease.

Yoshida Y, Hirano T, Son G, Iimuro Y, Imado T, Iwasaki T, Fujimoto J.

Am J Physiol Gastrointest Liver Physiol. 2007 Dec;293(6):G1114-23. Epub 2007 Aug 30.

11.

[Influence of donor Treg cells on GVHD and GVL effects after allogeneic bone marrow transplantation in mice].

Cao J, Chen C, Zeng LY, Li ZY, Cheng H, Pan XY, Xu KL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Feb;18(1):181-4. Chinese.

PMID:
20137143
12.

The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation.

Penack O, SociƩ G, van den Brink MR.

Blood. 2011 Apr 21;117(16):4181-9. doi: 10.1182/blood-2010-10-312934. Epub 2011 Jan 21.

13.

[Effect of endothelial progenitor cell on hematopoietic reconstitution in allogeneic hematopoietic stem cell transplantation mouse model].

Hua J, Fang T, Liu MM, Huang YJ, Fu JY, Wu JY, Xu KL, Zeng LY.

Zhonghua Xue Ye Xue Za Zhi. 2013 Jun;34(6):516-21. doi: 10.3760/cma.j.issn.0253-2727.2013.06.013. Chinese.

PMID:
23827111
14.

[Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].

Cao J, Li L, Chen C, Zeng LY, Li ZY, Pan XY, Xu KL.

Zhonghua Xue Ye Xue Za Zhi. 2011 Feb;32(2):83-8. Chinese.

PMID:
21429372
15.

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.

Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M.

Cochrane Database Syst Rev. 2014 Apr 20;(4):CD010189. doi: 10.1002/14651858.CD010189.pub2. Review.

PMID:
24748537
16.

Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature.

May C, Doody JF, Abdullah R, Balderes P, Xu X, Chen CP, Zhu Z, Shapiro L, Kussie P, Hicklin DJ, Liao F, Bohlen P.

Blood. 2005 Jun 1;105(11):4337-44. Epub 2005 Feb 8.

17.

[ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation].

Ran HH, Pan KL, Zhang R, Wang YF.

Zhongguo Dang Dai Er Ke Za Zhi. 2006 Oct;8(5):408-12. Chinese.

PMID:
17052403
18.

New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells.

Waller EK, Boyer M.

Bone Marrow Transplant. 2000 May;25 Suppl 2:S20-4.

PMID:
10933181
20.

[The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].

Li GP, Yang J, Hao J, Yang YM, Ren YN, Xie RF, Fan HH, Qian KC.

Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):461-6. Chinese.

PMID:
22967381

Supplemental Content

Support Center